The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland

•Awareness of COVID-19 was high among current and former people who inject drugs, but there were gaps in COVID-19 knowledge.•Current PWID may be less likely to adhere to COVID-19 prevention strategies.•Despite limited interruptions in healthcare, overdose prevention may be indicated, particularly in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol dependence 2021-04, Vol.221, p.108584-108584, Article 108584
Hauptverfasser: Genberg, Becky L., Astemborski, Jacquie, Piggott, Damani A., Woodson-Adu, Tanita, Kirk, Gregory D., Mehta, Shruti H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Awareness of COVID-19 was high among current and former people who inject drugs, but there were gaps in COVID-19 knowledge.•Current PWID may be less likely to adhere to COVID-19 prevention strategies.•Despite limited interruptions in healthcare, overdose prevention may be indicated, particularly in light of mental health concerns. There is limited data on the health and social consequences of the COVID-19 pandemic among people who inject drugs (PWID). We conducted a rapid telephone survey from April-June 2020 among participants of the community-based AIDS Linked to the IntraVenous Experience (ALIVE) cohort study in Baltimore, Maryland. This interviewer-administered survey collected information on COVID-19 knowledge, symptoms, testing, diagnosis, and prevention behaviors, recent substance use, housing conditions, interruptions to healthcare, access to harm reduction and drug treatment, mental health, and social support. Of 443 current and former PWID who participated in the survey, 36 % were female, 85 % were Black, 33 % were living with HIV and 50 % reported any substance use in the prior six months. COVID-19 awareness was high, but knowledge of symptoms and routes of transmission were lower. PWID reporting recent substance use were less likely to always socially distance (63 % vs. 74 % among those without recent use, p = 0.02), and Black PWID were more likely than non-Black to socially distance (73 % vs. 48 %, p < 0.0001) and use when alone (68 % vs.35 %, p < 0.01). Only 6% reported difficulty accessing healthcare, yet only 48 % of those on opioid-agonist treatment had a four-week supply available. While 34 % reported increased depressive symptoms, participants reported high levels of social support. This rapid assessment highlighted that PWID currently using drugs may be less able to practice social distancing and increased SARS-CoV-2 transmission may occur. Ongoing monitoring of substance use and mental health, as well as overdose prevention is necessary as the pandemic and public health responses continue.
ISSN:0376-8716
1879-0046
1879-0046
DOI:10.1016/j.drugalcdep.2021.108584